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ABSTRACT 
Background and Objectives 
 Swellings of thyroid are frequently encountered in surgical practice. 
Clinical evaluation helps in early diagnosis but it is difficult to distinguish 
early malignant lesions from the most prevalent benign goiters. Various 
diagnostic modalities are available to distinguish between benign from 
malignant thyroid nodules. Ultrasound forms an integral component in the 
evaluation of thyroid swellings. Thyroid Imaging Recording And Data 
System (TIRADS) is a classification system for thyroid nodules, which 
classify them into benign or malignant, based on ultrasound characteristics. 
Still histopathological examination is the goal standard for the classification 
of thyroid swellings. This study aims to assess the accuracy of TIRADS 
classification in the evaluation of thyroid swellings by comparing with 
cytological examination reports. 
 
Methodology 
A proforma was drafted for the study of all patients presenting with 
history of palpable thyroid swelling in our hospital. Clinical presentations, 
FNAC and Ultrasound findings of all cases were documented. Based on 
ultrasound findings, patients were grouped into different classes of TIRADS 
and findings compared with FNAC. 
 
13 
 
Results 
100 cases who presented with thyroid swellings were studied and their 
TIRADS class was compared with the FNAC. Out of the 100 cases, 93 were 
females and 7 were males, being 13.3 : 1.TIRADS 4b showed maximum 
frequency with 40 patients. TIRADS 4a included 16 patients, TIRADS 4c 
included 15 patients, TIRADS 2 included 11 patients, TIRADS 5 included 
10 patients, TIRADS 3 included 6 patients and TIRADS 1 included 2 
patients. TIRADS 4b, 4c and 5 showed malignant cases. TIRADS 4b showed 
7.5% malignant cases. TIRADS 4c showed 66.7% malignancy. TIRADS 5 
showed 100% malignancy. 
Interpretation and Conclusion 
The majority of our patients were between third and fourth decade, of 
which females being predominant. The majority of cases were benign of 
which colloid goiter being the most dominant pathology (62 %). Among the 
malignancies, majority were papillary carcinoma (60 %). Ultrasound thyroid 
is cheap, easy and can be done on outpatient basis. Addition of TIRADS 
score to clinical suspicion is very much helpful in picking up high risk cases, 
especially in a country like India where the rural patient load is very high 
and follow up is not standardized. TIRADS 4b showed 7.5% malignant 
cases. TIRADS 4c showed 66.7% malignancy. TIRADS 5 showed 100% 
malignancy. 
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INTRODUCTION 
Thyroid swelling is a common presentation in surgery department. 
Majority of these are benign diseases, of which goiter is the commonest and 
a few are malignant. The magnitude of problem in South East Asia is 
estimated to be around 172 million with goiters and Iodine deficiency is 
estimated to be around 600 million. It has been estimated that about 42 
million people in India suffer from thyroid diseases. Thyroid swellings are 
common clinical findings and have a reported prevalence of 4% to 7% in the 
adult population. Discrete thyroid swellings are common and are present in 
8.5% population in India. Thyroid swellings are four times more common in 
females. Thyroid swellings can be isolated or dominant. True incidence of 
thyroid nodularity is less apparent on clinical classification. When such 
glands are exposed at operation, clinically impalpable nodules may be 
detected. The usual presentation of thyroid disease is with swelling, pressure 
symptoms or signs of toxicity. Importance of solitary thyroid nodule is that 
the risk of neoplasia when compared to other thyroid nodules is high. Fifteen 
percent of STN are malignant. However, clinical presentation alone cannot 
differentiate benign from malignant. Complications of surgery are injury to 
RLN, hypoparathyroidism, life-long thyroid hormone replacement. The 
available tools to know the nature of a thyroid nodule are thyroid function 
tests, thyroid antibody titers, isotope scans, ultrasonography and fine needle 
aspiration cytology.  Cytological and histopathological examination still 
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remains the gold standard in evaluation of thyroid nodules. Ultrasonography 
is an important component in the work up of thyroid nodules. 
Ultrasonography provides advantages including portability, cost 
effectiveness, lack of ionizing radiations and non invasiveness. Hence 
clinical suspicion when coupled with ultrasound features, to a great extent , 
can categorize the patients into high risk or low risk. In a developing country 
like India , where patient load is high and man power available in health care 
is out of proportionally low ,cost effectiveness is very important. Thus 
ultrasound renders an important role in evaluation of thyroid nodule. To 
standardise ultrasound findings TIRADS classification can be used. TIRADS 
scoring system classifies thyroid nodules into 6 classes, based on certain 
sonographic features and thus help differentiate benign from malignant. 
Nevertheless ultrasound has lot of limitations including the difference in 
resolution of the equipment, observer variations and overlapping of findings. 
TIRADS classification tries to minimize these shortcomings. 
 
AIM OF THE STUDY 
To assess the accuracy of TIRADS classification in the risk stratification of 
thyroid swellings. 
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OBJECTIVES 
1. To determine the role of ultrasound in the diagnosis and management of 
thyroid disorders. 
2. To evaluate the accuracy of TIRADS classification in diagnosis of 
thyroid disorders. 
3. To distinguish between the malignant and benign solitary nodular 
lesions, thereby reducing the cost of unnecessary surgery for a benign 
lesion. 
4. To confirm the clinically obvious malignancy of thyroid thereby 
determining the type of surgery. 
 
REVIEW OF LITERATURE 
Historical aspects 
 Wharton in 1645 coined the term ‘thyroid’. Galen in 2 A.D, was 
aware of the existence of thyroid gland, but thought it was meant for 
lubrication of larynx. Sir Astley Cooper (1768-1841) suggested secretory 
function. Kendall (1965) first isolated Thyroxine-T4. Harrington and Banger 
(1927) first synthesized it. In 1953, Cross and Pitt-rivers and Roche, 
Liesitsky and Michel simultaneously discovered 3, 5, 3 Tri-iodothyronine. 
Radioactive iodine was introduced in 1934, was helpful in understanding 
thyroid physiology.  
 
22 
 
Early operations 
            The first credible account of thyroid surgery was given, by Roger 
Frugardi of Salerno in 1170. Pierre Joseph Desault (1744-1795) conducted 
the first partial thyroidectomy in Paris in 1791. By the 19th century, the 
advent of general anaesthesia (1840’s), antisepsis (1860’s) and haemostasis 
(1870’s), helped surgeons to undertake more thyroid operations, with greatly 
reduced morbidity and mortality. Between 1850 and 1977, the world wide 
operative mortality reduced to around 20%. During this period, both Theodor 
Kocher (1841- 1917) and Theodor Billroth (1829-1894) performed 
thousands of thyroidectomies, and success rate increased. Kocher discovered 
that development of myxoedema could be prevented by subtotal 
thyroidectomy. Kocher was awarded the Nobel Prize in 1909 for his works 
on the physiology,pathology and surgery on thyroid glands. Theoder Kocher 
is regarded as father of thyroid surgery. 
Fig. 1 . 
 
 
 
 
 
 
EMIL THEODOR KOCHER ( 1841-1917) 
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Embryology  
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 .   Thyroid embryology 
             At third week of gestation, thyroid arises as an outpouching from the 
primitive foregut . It originates from the base of tongue at the foramen 
caecum. The lateral anlages are neuroectodermal in origin (ultimobranchial 
bodies) and they develop into calcitonin producing parafollicular cells or C 
cells. 
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Surgical anatomy 
 
 
Figure 3. Thyroid gland, anterior view 
The adult thyroid gland is brownish-red in colour and is situated in the 
lower neck anteriorly, from the level of the fifth cervical vertebra down to 
the first thoracic vertebra, overlying second to fourth tracheal rings.  
Thyroid weighs about 20 gm in adults (it is slightly heavier in 
women). Thyroid glands are located adjacent to the thyroid cartilage, and the 
isthmus is located just below the cricoid cartilage. A pyramidal lobe is seen 
in about 50% of patients. Two pairs of parathyroid glands lie in close 
proximity to the thyroid gland. 
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Nerve supply of the thyroid 
Main nerve supply of the thyroid gland is from the autonomic nervous 
system. Parasympathetic fibers are derived from the vagus nerves, and 
sympathetic fibers are distributed from the superior, middle, and inferior 
sympathetic ganglia . 
Ligament and fascia 
The thyroid gland is ensheathed by a division of the middle layer of 
deep cervical fascia, which attaches it firmly to the laryngeal skeleton.   
Vascular supply 
The arterial supply to the thyroid gland comes from the superior and 
inferior thyroid arteries and a small percentage from the thyroid ima. The 
superior thyroid artery is the first branch of the external carotid artery.  The 
inferior thyroid artery is a branch of thyrocervical trunk, which again is a 
branch of the subclavian artery. The inferior thyroid artery is closely 
associated with the recurrent laryngeal nerve.  
Venous Drainage 
      Venous drainage for the thyroid gland is provided by three pairs of veins. 
The superior thyroid vein runs along with the superior thyroid artery and 
drains into the internal jugular vein. The middle thyroid vein drains directly 
and laterally into the internal jugular vein. The inferior thyroid veins have 
different paths on either side.  
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Nerve supply 
The left recurrent laryngeal nerve arises from the vagus nerve where it 
crosses the aortic arch and loops around ligamentum arteriosum and ascends 
in the neck in the tracheoesophaeal groove. The right recurrent laryngeal 
nerve arises from the vagus at the level of the right subclavian artery.  
Lymphatics 
      Lymphatic drainage of thyroid gland is extensive and flows 
multidirectionally. Intraglandular lymphatic vessels connect both lobes of 
thyroid through isthmus and drain into perithyroid structures and lymph 
nodes. Regional lymph nodes include pretracheal, and paratracheal, 
periglandularnodes; which drain to the prelaryngeal (Delphian), nodes ; to 
retrophayngeal, esophageal, and superior mediastinal, upper,middle and 
lower jugular lymph nodes. There can also be “skip” metastasis to nodes in 
the ipsilateral neck. 
Structure 
       The thyroid has an inner true capsule under the middle layer of deep 
cervical fascia, which is very thin and adheres closely to the gland. 
Extensions of this capsule form numerous septae within the substance of the 
gland, which divide the gland into lobes and lobules. The lobules are formed 
of follicles (200-900 microns), which forms the structural unit of the gland. 
The follicle is lined by a single layer of cells, which may vary from flattened 
to cuboidal cells depending on activity and enclosing a colloid filled cavity. 
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The colloid contains an iodinated glycoprotein – iodothyroglobulin 
which is a precursor of thyroid hormones. Epithelial cells are of 2 types - 
principal cells (follicular) and parafollicular cells (C, clear, light cells). 
Principal cells are responsible for formation of the colloid 
(iodothyroglobulin), whereas parafollicular cells produce calcitonin, a 
hormone central to calcium homeostasis. Parafollicular cells lie adjacent to 
the follicles within the basal lamina. 
Cytology of normal thyroid gland 
 
 
 
 
 
 
Fig. 4 :Normal thyroid histology- Follicular cells surround colloid 
Physiology 
The primary function of thyroid is the production of sufficient thyroid 
hormone for regulation of cellular metabolism throughout the body. The 
thyroid hormones triiodothyronine (T3) and L-thyroxine (T4) {extracted by 
Kendall EC in 1953} are bound to thyroglobulin in the colloid. 
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Iodine metabolism 
      Iodine is taken in the form of Iodides. Sea fish, egg and milk are good 
dietary source of iodine. Dietary iodide gets absorbed from upper GIT and is 
carried as inorganic iodide in the plasma. Thyroid and kidney are the 
principal organs involved in iodine metabolism. 
An adult man requires 0.15 mg of iodine per day and an adult female 
requires 0.10 mg. Children, pregnant and lactating women require more 
iodine. The daily requirement is met by diet and drinking water, except in 
hilly areas where food and water may be deficient in iodine. 
Synthesis, secretion and transport of thyroid hormones 
Four steps are involved in the synthesis of thyroid hormones : 
1)Iodine trapping 
Iodine is trapped in the inorganic form by the thyroid.  
 
 
 
 
 
 
 
 
Fig. 5 : Synthesis, secretion and transport of thyroid hormones 
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2)Iodine binding 
The inorganic iodide is oxidized to iodine in the thyroid follicular cells 
by an enzyme peroxidase.  
 
3)Coupling 
      Coupling of two molecules of DIT produce Thyroxine (T4) . 
Triiodothyronine (T3) is formed by coupling of one molecule each of MIT 
and DIT. They are oxidation reactions and need peroxidase enzyme. 
 
4)Hormonal release 
     At first Thyroglobulin is taken up by the follicular cells. TSH a protease 
acts on thyroglobulin to form T4, T3, MIT and DIT. T4 and T3 directly 
enters the circulation from the follicular cells. On entering the circulation, 
thyroid hormones are largely bound to specific transporter proteins called 
thyroxine-binding globulin (TBG), thyroxine binding albumin and thyroxine 
binding prealbumin (TBPA).  
Differences between T3 and T4 
T3 has quicker onset of action and is effective in small doses. It is 
three to four times more active than T4. The onset of action of T3 is within 6-
8 hours while that of T4 lasts for 4-14 days. The half life of T3 is 1 day while 
that of T4 is 7 days. T3 is physiologically more important, reverse T3 is an 
inactive form of T3. 
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Regulation of thyroid function 
Regulation of thyroid function is by two mechanisms - suprathyroid 
and intrathyroid regulations. The suprathyroid regulation is mediated by 
thyroid stimulating hormone (TSH). The intrathyroidal regulation is an 
autoregulatory mechanism. The thyroid reduces the iodine trapping when 
there is sudden increase in the supply of iodide, without the negative 
feedback mechanism. 
Etiology of benign disorder 
Over stimulation of thyroid gland by TSH produces simple goiter, 
overstimulation may be due to either a microadenoma in the anterior 
pituitary which produces inappropriate secretion of TSH (which is rare) or in 
response to a low level of circulating thyroid hormones.Defective synthesis 
of thyroid hormones also produces some sporadic goiters. 
(a) Iodine deficiency 
Daily iodine requirement is about 0.1 to 0.15 mg.In places where simple 
goiter is endemic, there is very low iodine content in food and water. 
However in situations where iodine excess occurs, disease processes such as 
Hashimoto’s thyroiditis and Grave’s disease can occur.  
(b) Chemical goitrogens 
Iodides in large quantities can inhibit organic binding of iodine and 
produce goiter (Wolf – Chaikoff  effect). 
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(d)Drugs as goitrogens 
Brassica family vegetables (cabbage, rape and kale) which contain 
thiocynate and drugs like PAS (para-amino salicylic acid) and anti thyroid 
drugs are goitrogens. 
Thiocynates and perchlorates inhibit iodine trapping, while carbimazole 
and thiouracil compounds inhibit oxidation of iodide and interfere with 
binding of tyrosine.Massive steroid therapy may result in functional 
hypothyroidism. 
(d) Genetics and immunology 
Grave’s disease is associated with Human Leucocyte Antigen (HLA) 
haplotypes – HLA-B8, HLA- DR3 and HLA – DQAI.The hypertrophy and 
hyperplasia is caused by abnormal thyroid stimulating antibodies (TSH-
RAb) that bind to TSH receptor and produce a disproportionate and 
prolonged effect. 
Etiology of malignancy  
(a)Radiation 
Papillary carcinoma is associated with irradiation of thyroid gland 
below 5 yr of age. Mean age of  presentation is 30 to 40 yrs. Patients who 
have received external radiation for soft tissue malignancy like Hogdkin’s 
lymphoma are at increased risk of developing malignancy. 
(b)Raised TSH levels 
Raised TSH stimulation increase the incidence of follicular carcinoma. 
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(c)Genetic predisposition 
Sporadic, familial medullary and follicular carcinomas are associated 
with RET oncogen mutation. RET/PTCB is associated with short latency 
aggressive papillary carcinoma. P53 mutation is associated with 
undifferentiated thyroid cancer and thyroid cancer cell lines. PAX 8 gene is 
found to have an important role in follicular neoplasms, including follicular 
carcinomas. 
PATHOLOGY 
 A normal thyroid gland is not palpable.  ‘Goiter’ ( latin - gutter= throat) is 
used to describe the generalised enlargement of thyroid gland. A discrete 
swelling (nodule) with no other palpable abnormality in the thyroid gland is 
termed as solitary or isolated swelling. Discrete swelling with abnormality 
elsewhere in the gland is termed as dominant. Thyroid enlargement can be 
categorized as follows: 
CLASSIFICATION OF THYROID SWELLINGS 
1. Simple goiter (Euthyroid) 
Diffuse hyperplastic  
-Pubertal 
-Physiological 
-Pregnancy 
Multinodular goiter 
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2. Toxic      
Toxic adenoma 
Multinodular 
Diffuse- Graves disease 
3. Neoplastic 
Benign 
-Follicular adenoma 
-Papillary adenoma 
-Atypical adenoma 
-Hyalinisingtrabeculated adenoma 
Malignant 
                      -Papillary carcinoma 
                -Follicular carcinoma 
-Medullary carcinoma 
-Anaplastic carcinoma 
-Poorly differentiated carcinoma 
4. Inflammatory         
Autoimmune 
-Chronic lymphocytic thyroiditis 
-Hashimoto’s thyroiditis 
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Granulomatous 
-De Quervain’s thyroiditis                     
Fibrosing 
-Reidel’s thyroiditis  
Infective 
-Acute –   Bacterial thyroiditis 
        Viral thyroiditis 
         Subacute thyroiditis 
-Chronic – Tubercular, Syphilitic, etc. 
-Others  
-Amyloid 
DIAGNOSIS 
The diagnosis of thyroid diseases is based on the evaluation of thyroid 
functions and based on the nature of the lesion, benign or malignant. 
INVESTIGATIONS 
ESSENTIAL 
A) Serum 
TSH (T4 and T3, if abnormal ) 
TAA (Thyroid auto antibodies ) 
B) FNAC 
Fine needle aspiration cytology of all discrete palpable swellings. 
C) Ultrasound Neck 
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OPTIONAL 
A) Calcium and albumin 
B) Chest radiography and thoracic inlet to rule out deviation of trachea 
and retrosternal extension  
C) CT / MRI are rarely indicated 
   D) Isotope scan if discrete swelling and toxicity co-exist. 
 
TESTS OF THYROID  
Serum TSH 
Serum TSH levels (0.5 to 5 microU/ml-normal) can be measured to 
even very low concentrations by radiochemiluminometric assay.  
The ultrasensitive assays can detect TSH levels as low as 0.01 
microU/ml. There is an inverse relationship between free T4 level and 
logarithm of TSH level.Hence small changes of free T4 can lead to large 
changes in TSH levels. So, the ultrasensitive TSH levels have become more 
sensitive and specific test for the diagnosis of hypo or hyperthyroidism, and 
for optimizing the T4 suppressive and replacement therapy. 
 
Triiodothyronine (T3) and Thyroxine (T4)   
The total T4( normal- 55 to 150 nmol/L) and T3 (normal-1.5 to 3.5 
nmol/L) levels can be measured by radioimmunoassay. Both the free levels 
and bound levels of the hormones can be measured. Only a small level of 
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both T3 and T4( 0.03% of T4 and 0.3% of T3) are free and physiologically 
active. T3 toxicity (normal T4) is a separate entity and can be diagnosed by 
measuring the serum T3(suppressed TSH with a normal T4 level is 
suggestive). 
 
ULTRASOUND 
It is an excellent noninvasive imaging modality. It is helpful to 
distinguish between sloid and cystic lesions in thyroid nodules. It also 
provides information about size and multicentricity. It is also used to assess 
lymph node status and for guided FNAC, especially B-mode that can be used 
preoperatively and intraopertively. 
 
CT / MRI SCAN 
It gives excellent view of the thyroid gland and the adjacent lymph 
nodes. It is particularly useful in evaluating large, fixed and substernal 
goiters and their relationship with trachea and vascular structures. Non-
contrast CT should be done in patients with possibility of further radioactive 
iodine therapy. 
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FNAC and HPE of THYROID LESIONS 
1. Low cellular smears are benign and high cellular smears are 
suspicious. 
2. Degenerative changes and old haemorrhages are seen as histiocytes, 
which are seen as large cells with peripherally pushed pyknotic nuclei 
and cloudy cytoplasm, with many vacuoles and granules of degraded 
or digested material. 
3. Hurtle cells look longer than follicular cells, with well defined cellular 
borders, granular cytoplasm and moderate to large nuclei. 
4. Inflammations and malignancy can be ruled out.  
 
THYROID ANTIBODIES 
These are anti-thyroglobulin (anti-Tg), anti-thyroid peroxidase (anti- 
TPO) and thyroid stimulating immunoglobulins (TSI). They are used to 
evaluate thyroid dysfunction and swellings. Auto immune thyroiditis may be 
associated with simple goiter or failure or thyrotoxicity. Levels above 25 
units per ml of TPO antibody and titres above 1:100 for antithyroglobulinare 
significant, but a large proportion of patients with histological evidence of 
lymphocytic (auto-immune) thyroiditis may be seronegative. 
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SERUM THYROGLOBULIN 
Thyroglobulin is normally not found in circulation in large amounts, 
but its levels increases drastically in destructive processes of thyroid like 
thyroiditis or in overactive states like Graves disease and toxic multinodular 
goitre. The most important use of thyroglobulin is in monitoring the patients 
with differentiated thyroid cancer, following total thyroidectomy or 
radioactive iodine ablation for recurrence. 
 
ISOTOPE SCANNING 
Iodine-123(123I ) and iodine-131 (131I) are used to scan thyroid. 123I 
emits low dose iodine which can be used to image lingual thyroid or goitre. 
131I produces higher dose of radiation exposure  and its used to treat patients 
with differentiated thyroid cancer for metastatic disease. 
Routine use of isotope scan is not necessary and it cannot be used for 
distinguishing benign from malignant lesions, because majority of cold 
swellings are benign (80%) and small number(5%) of functioning or warm 
swellings are malignant. It is mainly used in the toxic patient with 
nodularity. Localization of overactivity in the gland is used to differentiate a 
toxic nodule from a toxic MNG with several areas of increased activity in 
the gland. 
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Technetium – 99m (99mTc) pertechnetate is also used for thyroid evaluation 
and it has a shorter half- life and minimum radiation exposure. Its 
particularly sensitive to nodal metastasis. 
A.Suppurative  thyroiditis 
Acute suppurative thyroiditis from bacterial infections is rare. The 
aspirates are highly cellular consisting of neutrophils, macrophages and 
cellular debris. 
B. Sub acute (de Quervain’s thyroiditis) 
 Aspirates demonstrate presence of lymphocytes, plasma cells,    
epithelioid histiocytes and multi nucleated giant cells containing 30 – 300 
nuclei. 
C. Hashimoto’s thyroiditis 
Lymphocytic thyroiditis (Hashimoto’s thyroiditis) is an auto immune 
disease that can present as diffuse enlargement of thyroid or as solitary or 
multiple nodules.  Fine needle aspiration usually consist of numerous 
lymphocytes and plasma cells with follicular cells showing oncocytic 
features   (Hurtle cells). Hurtle cells contain dense abundant granular 
cytoplasm and may possess hyperchromatic highly atypical nuclei. The 
recognition of Hashimoto’s thyroiditis is difficult for the cytopathologist, 
especially when only inflammatory or and epithelial components are present. 
This can produce false positive diagnosis of lymphoma or carcinoma, 
especially Hurtle cell tumour. 
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D. Riedel’s struma 
The aspirate contains mature lymphocytes and some fibroblasts. 
 
BENIGN NON NEOPLASTIC LESIONS 
A. Non toxicGoitres 
1) SIMPLE GOITRE (COLLOID GOITRE) 
The smear is scanty or moderately cellular with large amounts of 
colloid and epithelial cells, the cells are arranged in discrete fashion, in 
clusters and in sheets. 
2) MULTINODULAR GOITRE  
Smear shows plenty of colloid in the background of which, epithelial 
cells are found in microfollicle formation and cyst macrophages together 
gives a chess board pattern. Hemosiderin laiden macrophages and histiocytes 
are usually conspicuous. Microscopically, there is partially or completely 
encapsulated nodules, which exhibit focal cystic degeneration and necrosis. 
There is colloid distended follicles of various sizes and shapes separated by 
fibrous bands. 
B.Toxicgoitre 
Smears are bloody with flare cells,naked nuclei and follicular cells 
with abundant finely granular cytoplasm and peripheral vacuoles. 
Follicles are of diversified size and shape with variable amounts of 
colloid. 
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Epithelium is highly columnar, sometimes multilayered, and may 
protrude into the lumen, suggesting a papillary neoplasm. 
 
NEOPLASMS 
A. Follicular neoplasm 
Cytologically it is quite difficult to differentiate between follicular 
adenoma and follicular carcinoma. Unless vascular and capsular invasion is 
evident, it is difficult even in histology. Hence both follicular adenoma and 
carcinoma are both excised. The following are certain distinguishing 
features: 
a) Follicular adenoma 
The aspirate contains scanty colloid. The cells have microfollicular 
structure with small, round, and uniform nuclei. 
(b)Follicular carcinoma 
The aspirate is bloody with isolated follicles or follicles which are laid 
in small sheets. The cells shows atypia to frankly malignant transformation. 
The nuclei are large, oval and eccentric, better appreciated by plantimeteric 
study. Benign lesions demonstrate honey-comb, sheets of follicular cells. 
Over lapped, crowded cells indicate well differentiated follicular carcinoma. 
Histologically, it may be apparently encapsulated or diffusely 
infiltrating, well or poorly differentiated. It is differentiated morphologically 
from adenoma by capsular and vascular invasion. 
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B. Papillary carcinoma 
Papillary carcinomas may present as solitary or multifocal lesions 
within the thyroid. They can be well circumscribed or encapsulated; but 
sometimes it may infiltrate the adjacent parenchyma showing ill-defined 
margins. Macroscopically, they may be granular or may show grossly visible 
papillary foci.  
The diagnosis of papillary carcinoma is based on individual cellular 
morphology. The nuclei is characteristically empty and pale staining, giving 
rise to the so called "ground-glass" or "Orphan Annie eye" nuclei. There may 
be cytoplasmic invaginations giving rise to the appearance of intranuclear 
inclusions (hence the term pseudo-inclusions) . Sloughed papillary 
projections produce concentric calcified structures termed ‘psammoma 
bodies’ within the papillae. 
C. Medullary carcinoma 
Microscopically, smears of medullary carcinomas are composed of 
polygonal to spindle-shaped cells. They may organize form nests, trabeculae, 
or even follicles. Acellular amyloid deposits, derived from altered calcitonin 
molecules, are present in the adjacent stroma in most cases and are a 
characteristic feature of these tumors. Calcitonin is demonstrable both within 
the cytoplasm and in the stroma by immunohistochemical methods. Familial 
medullary carcinomas shows multicentric C-cell hyperplasia in the 
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surrounding thyroid parenchyma, a feature which is usually absent in 
sporadic lesions. 
D. Anaplastic carcinoma     
Microscopically, anaplastic neoplasms are composed of anaplastic cells, 
which may show several histologic patterns, including 
(1) Large, pleomorphic giant cells 
(2) Spindle cellsshowing sarcomatous appearance 
(3) Mixed spindle and giant-cell lesions 
(4) Small cells 
Foci of papillary or follicular differentiation may be present in some, 
suggesting origin from a better differentiated carcinoma. 
E.Hurtle cell neoplasms 
Hurtle cell adenoma 
It is a variant of follicular neoplasm, smear demonstrates large 
follicular cell devoid of follicular structures. Microscopically it contains 
follicles with regular epithelium, colloid may be abundant or absent. 
It is difficult to differentiate between benign and malignant Hurtle cell 
tumours. The cells are oval to polyhedral with abundant granular cytoplasm 
and a prominent large eccentric nucleus. 
The cells are isolated or arranged in loose groups, marked nuclear 
pleomorphism indicates malignancy. 
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Fig. 6 .Normal  thyroid follicle lined by thin layer of cuboidal follicular 
epithelial cells 
 
Fig. 7 .Hashimotos thyroiditis 
 
 
Fig. 8 .Gross specimen of follicular adenoma. 
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Fig. 9.Follicular adenoma with no capsular or vascular invasion. 
 
Fig. 10.Capsular invasion of follicular carcinoma. 
 
Fig. 11.Vascular invasion of follicular carcinoma. 
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Fig. 12.Hurtle cell adenoma 
 
 
Fig.13. Medullary carcinoma with amyloid stroma. 
 
Fig. 14.Papillary carcinoma 
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FINE NEEDLE ASPIRATION CYTOLOGY 
Aspiration biopsy cytology is a branch of diagnostic cytology that 
analyze cells harvested from the organs, tumours and non neoplastic 
abnormal tissues to arrive at a diagnosis( Joseph and Link 1983). 
The technique of fine needle aspiration (FNA) was developed in New 
York city at Memorial Hospital in the 1920s. But it was popularized in the 
Europe years later, particularly in Scandinavian countries, where its safety 
and accuracy were fully established. Later it was brought back to United 
States where it was widely used for lesions of thyroid,breast , salivary 
glands, and lungs. It was carried out with a fine needle and sometimes under 
image guidance. The procedure was found to be with no doubt inexpensive, 
safe, quick and when performed in experience hands – quite accurate. 
 
ADVANTAGES OF FNAC 
1. The technique is safe, simple and acceptable to most patients. 
2. It can be done without any preparation or anaesthesia. 
3. It takes less than 5 minutes to perform and its interpretation is also 
rapid,can be reported within an hour.  
4. Representative sample is taken because the needle enters various areas of 
the nodule. 
5. If an inadequate sample was obtained in the first instance the technique 
can be repeated without much patient discomfort. 
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6. It is an accurate and cost effective investigation and does not require 
hospital admission and can be done in an out-patient basis. 
7. It is less traumatic and is of less complications. 
8. From this technique definite morphological diagnosis can be made . 
9. Cysts can be aspirated completely and thus it can be therapeutic too in 
such instances. 
 
DISADVANTAGES OF FNAC 
1. Minimal material is available for examination,so architecture and cell 
relationship cannot be made out. 
2. Due to cystic lesions and cystic areas in thyroid, inadequate material may 
be aspirated . 
3. The needle may miss important areas in the nodule despite a good 
attempt. 
4.  Distinction between follicular adenoma and follicular carcinoma is 
difficult as it needs capsular and vascular invasion to differentiate 
between the two. 
5.  Good cytopathologist is essential to interpret the results. 
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ACCURACY OF FNAC 
(According to the study of Orrel SR et al)  
     Colloid goiter (simple nodular) – 96% 
Hashimoto’s thyroiditis – 90 to 95% 
Papillary carcinoma of thyroid – 60 to 90% 
   Follicular carcinoma of thyroid – 70% 
Grave’s / Plummer’s disease – variable ( needs clinical and 
biochemical correlation). 
 
COMPLIATIONS OF FNAC 
Even though FNAC is considered a simple and safe procedure it may 
be associated with some complications which are encountered rarely: 
1. Local discomfort. 
2. Minor hematoma. 
 
PITFALLS OF FNAC  
Inadequate sampling : This could be because of poor cell in aspirate 
(as in cases of cyst or Hashimoto’s thyroiditis or Riedel’s thyroiditis) or 
haemorrhagic (as in adenoma or hyperplastic  nodule ). So second or a third 
attempt becomes mandatory.The percentage of unsatisfactory smears from 
various studies is found to be 0 to 20 %. 
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1. Geographical misses  
2. Interpretational inaccuracies: Interpretation depends on the experience 
of the cytopathologist. 
 
ULTRASONOGRAPHY 
Ultrasound was first used for medical purposes by Dr George Ludwig in the 
late 1940s at the Naval Medical Research Institute, Bethesda, Maryland, . 
Physicist John wild (1914–2009) first used ultrasound to assess the thickness 
of bowel tissue (1949); he is known as the "father of medical ultrasound". 
Ultrasound is sound waves with frequencies higher than the audible  
frequency range. Ultrasound images are known as sonograms. Pulses of  
ultrasound are send into tissue using a probe. The sound echoes back  
off the tissue,with different tissues reflecting different degrees of sound.  
These echoes are recorded and displayed as an image . 
Different types of images can be formed using ultrasound. B-mode  
image,which is the commonly used mode ,displays the acoustic impedance  
of a two-dimensional cross-section of tissue. Other types of image are used  
to demonstrate blood flow, motion of tissue ,the location of blood, the  
stiffness of tissue, or the anatomy of a region. 
The frequency commonly used for medical imaging is in the range of 1 to  
18 MHz. A sound wave is produced by a piezoelectric transducer.the sound  
waves reflected from the target tissue is received by the transducer.The 
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transducer converts the vibrations into electrical energy that travel to the  
ultrasonic machine where they are processed and transformed into a digital  
image. Whenever a sound wave encounters a material with a different  
density (acoustical impedance), only part of the sound wave is reflected  
back . The time taken for the echo to travel back to the probe is measured to  
calculate the depth of the tissue. If there is gas or solid structures, the  
density difference is so great that most of the acoustic energy is reflected and  
Hence it becomes impossible to see deeper. 
Different modes available in ultrasound are: 
A-mode: (amplitude mode) is the simplest type of ultrasound. It is used for 
depth assessment. 
B-mode or 2D mode: In B-mode (brightness mode) ultrasound, a linear  
array of transducers simultaneously scans a plane through the body that can 
be viewed as a two-dimensional image on screen.  
C-mode - A C-mode image is formed in a plane normal to a B-mode  
Image, but faster. 
M-mode: (motion mode) This is used to determine the velocity of specific 
organ structures. 
Doppler mode: This mode makes use of the Doppler effect in measuring  
and visualizing blood flow. 
     Colour doppler 
     Continuous doppler 
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     Pulse wave doppler 
     Duplex 
Pulse inversion mode 
Harmonic mode 
Advantages 
1.  It is useful for delineating the interfaces between solid and fluid-filled 
spaces. 
2. It renders dynamic imaging. Live images also allow for ultrasound-
guided biopsies or injections. 
3. It shows the structure of organs. 
4. It has no long-term side effects and does not cause any discomfort to 
the patient. 
5. It is easily available and cheap. 
6. Small, easily carried scanners are available so that bed side 
examinations can be done. 
7. Relatively inexpensive compared to other modes of investigation, such 
as CT, MRI. 
8. Spatial resolution can be assessed in a better way in high frequency  
9. ultrasound transducers than in most other imaging modalities. 
10. It can be used to direct interventional procedures like FNAC or 
aspiration in doubtful cases. 
 
53 
 
Disadvantages 
1. Ultrasound cannot be used to visualise deep to bone.  
2. If there is interveining air, deeper structures cannot be assessed. 
3. The depth penetration of ultrasound depends on the frequency of 
imaging. So there may be difficulties imaging structures deep in the 
body, especially in obese patients. 
4. Body habitus has a large influence on image quality.  
5. The  modality is operator-dependent. . 
6.  Once an image has been acquired there is no exact way to tell which 
part of the  body was imaged. 
 
Fig.15. ultrasound machine 
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TIRADS CLASSIFICATION 
Thyroid Imaging and Reporting System (TIRADS) was proposed 
similar to BIRADS classification. It was proposed by Howarth. The 
classification is used to differentiate thyroid swellings into benign or 
malignant without invasive procedures, based on ultrasound evaluation of 
thyroid using suspicious Sonographic features. 
 
CLASSIFICATION 
TIRADS 1 - Normal thyroid gland 
TIRADS 2 - Benign gland 
TIRADS 3 - Probably benign 
TIRADS 4 - Suspicious lesion 
TIRADS 5 - probably malignant 
TIRADS 6 - proven malignant 
 
SUSPICIOUS SONOLOGICAL FACTORS 
1. Solid components 
2. Hypoechogenicity 
3. Microcalcification 
4. Taller than wider 
5. Irregular margins 
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TIRADS 1 
Normal thyroid gland with no features of nodularity or enlargement of 
thyroid. 
TIRADS 2 
Thyroid nodule without suspicious sonographic features but,iso /  
hyperoechoic, vascular,expansile and capsulated. 
TIRADS 3  
Thyroid nodule without suspicious sonographic features but 
heteroechoic, and partially formed capsule and peripheral vascularization. 
TIRADS 4 
TIRADS 4a - one of the suspicious sonographic features. 
TIRADS 4b - two suspicious sonographic features. 
TIRADS 4c - three / four suspicious sonographic features. 
TIRADS 5  
All of the suspicious sonographic features. 
TIRADS 6 
Biopsy proven malignancy. 
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Fig.16 : solid components 
 
 
Fig.17 :Hypoechogenicity 
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Fig.18 :Microcalcification 
 
 
.Fig.19 : Taller than wide  
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Fig.20 : Irregular margins 
 
 
METHODOLOGY 
The study includes those patients admitted in the surgical wards of 
Tirunelveli Medical College Hospital from January 2014 to June 2015 for 
treatment of thyroid diseases. 
 
Study design :  A prospective study. 
Place   : Tirunelveli Medical College Hospital  
Study period : From January 2014 to June 2015. 
Source of data :  Patients with thyroid swelling having admitted for 
thyroid surgery in the wards of Department of 
Surgery, Tirunelveli Medical College Hospital 
during the study period. 
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Sample size and method: 
A total of 100 patients with thyroid swelling were studied. 
SELECTION CRITERIA 
INCLUSION CRITERIAS 
The study includes those patients- 
1. Getting admitted in the surgical wards for the treatment of various 
thyroid swellings. 
2. Who are willing to co-operate for the study.   
 
EXCLUSION CRITERIAS 
The study excludes those patients  
1. children below 12 years. 
2. Not willing for FNAC. 
3. Lost for follow up. 
 
PROCEDURE 
Patients with goiter were evaluated clinically. Relevant aspects of 
patient’s history including age, sex, rapidity of growth, recent onset of 
hoarseness, dysphagia, dyspnoea, symptoms of hypo or hyperthyroidism, 
history of head and neck irradiation, family history of endocrine diseases 
were included.  
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Physical examination to determine whether the gland was diffusely 
enlarged, solitary, nodular or multinodular with symmetric or 
asymmetric enlargement was done. In nodular swelling, the size, shape, 
consistency, location and mobility was assessed. The patient was also 
examined for the presence of cervical lymphadenopathy. 
A thyroid function test and an ultrasound were performed using a 7.5 
MHZ high frequency linear array transducer. FNAC was carried out in 
the Department of Pathology, Tirunelveli Medical College Hospital. The 
ultrasound findings were classified into various classes of TIRADS and 
the same compared with FNAC diagnosis. 
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RESULTS 
The results of the 100 patients studied with their FNAC and 
TIRADS classification are as follows: 
Age and Sex distribution 
Table : 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MALE FEMALE TOTAL 
AGE    
10 - 20y    
20 - 30  4 4 
30 - 40  33 33 
40 - 50 3 24 27 
50 - 60 1 18 19 
60 - 70  11 11 
70 - 80 3 3 6 
TOTAL 7 93 100 
 Fig.21.  Bar diagram of Age
Sex Distribution 
Table 2.Sex distribution in thyroid swellings
 
DISTRIBUTION 
 
Fig.22. Bar diagram showing Sex distribution
 
- Sex distribution
 
MALE FEMALE TOTAL 
7 93 100 
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 Fig.23. Pie chart showing sex distribution
Majority of the patients were in the fouth and fifth decade of life with 
a female predominance in all age groups. The female to male ratio in our 
study was found to be 13.2 :1. But above 70 years we had equal number of 
male and female patients.
BIOCHEMICAL STATUS
Table 3.Distribution of biochemical status
 
EUTHY
ROID 
HYPOTH
YROID
FREQU
ENZY 
86 
 
 
 
 
 
 
 
 
 
 
HYPERT
HYROID 
S/C 
HYPOTHY
ROIDISM 
HYPERTHY
ROIDISM
3 7 3 
63 
S/C 
 
TOTAL 
1 100 
 Fig.24. Bar diagram showing biochemical status
Fig.25. Pie chart showing biochemical status
Of the 100 patients studied, 86 of them were euthyroid, 3 hypothyroid, 7 
hyperthyroid, 3 subclinical hypothyroidism and 1 subclinical 
hyperthyroidism, 
 
 
 
 
64 
 
 Differential diagnosis of thyroid swellings
Table 4.Distribution of 
 
COL
LOID 
GOI
TRE 
HAS
HIM
OTO
S 
ANA
PLAS
TIC 
CA
FRE
QUE
NZY 
62 11 1
 
Fig.26. Bar diagram showing differential diagnosis 
 
differential diagnosis of thyroid swellings
 
PAPI
LLR
Y CA 
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NOM
A 
MAL
IGNA
NCY 
NOR
MAL 
LYMP
HOCI
TIC 
 12 2 3 2 3 
of thyroid swellings
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FOL
LICU
LR 
HUR
THLE 
CELL 
TOT
AL 
3 1 100 
 
 
 Fig.27. Pie chart showing differential diagnosis of thyroid swellings
Majority of the thyroid swellings were found to be colloid 
goitre,which constituted 62 patients of the total 100 studied. 12 cases of 
papillary carcinoma, 11 
each of lymphocytic thyroiditis and non specified malignancy, 2 cases of 
adenomatous goitre and normal thyroid gland and1 case of anaplastic 
carcinoma were the other pathologies noted.
MALIGNANCY IN THYROID
Table 5.Distribution of malignancy
 
ANAPLAS
TIC 
FREQUEN
ZY 
1 
 
 
Hashimotos thyroiditis, 4 follicular neoplasms, 3 
 
 SWELLINGS 
 
PAPILLARY FOLICULAR 
NOT 
SPECIFIED
12 4 3 
66 
 
 
 
TOTAL 
20 
 Fig. 28. Bar diagram showing Distribution of malignancy
Fig. 29. Pie chart showing Distribution of malignancy
 
Of all the malignancies papillary carcinoma constitutes 60%, follicular 
neoplasm 20%, not specified malignancy 15% and anaplastic carcinoma 5%.
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AGE DISTRIBUTION IN DIFFERENTIAL DIGNOSIS 
Table 6 .Age distribution in differential diagnosis 
 COLL
OID 
GOIT
RE 
HASH
IMOT
OS 
ANAP
LAST
IC CA 
PAPIL
LRY 
CA 
ADE
NO
MA 
MALI
GNA
NCY 
NOR
MA
L 
LYMP
HOCI
TIC 
FOLL
ICUL
R 
HURT
HLE 
CELL 
TO
TA
L 
AGE 
10 - 20y            
20 - 30  3  1        
30 - 40 24 1  4     2   
40 - 50 19 2    2 2 3 1   
50 - 60 13 3  3        
60 - 70 5 2 1  2 1      
70 - 80 1   4      1  
TOTAL 62 11 1 12 2 3 2 3 3 1 100 
 
 
 
 
 
 
 
 Fig.30. Bar diagram showing Age distribution in differential diagnosis
Fig.31. Component Bar diagram showing Age distribution in differential 
diagnosis 
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 Benign disorders mainly 
but for malignancy there we found an increased incidence in the fourth 
decade and also above 65 years.
 
TIRADS CLASSIFICATION
Table 7.Distribution in TIRADS scoring system
 
FREQUENCY 
 
 
Fig. 32. Bar diagram showing Distribution in TIRADS scoring system
 
 
 
 
 
affected the fourth and fifth decade of life, 
 
 
 
1 2 3 4a 4b 4c 5 
2 11 6 16 40 15 10 
70 
6 TOTAL 
 100 
 
 
 Fig.33. Pie chart showing Distribution in TIRADS scoring system
The 100 cases were grouped into various classes of TIRADS. 
TIRADS 1 - 2%; TIRADS 2 
TIRADS 5 - 10%. 
 MALIGNANCY DISTRIBUTION IN TIRADS CLASSES
Table 8.Malignancy distribution in TIRADS scoring system
 
 
 
 
 
 
 
 
 
 
TIRADS
1 
2 
3 
4a 
4b 
4c 
5 
 
- 11%; TIRADS 3 - 6%; TIRADS 4 
 BENIGN MALIGNANT
100 0 
100 0 
100 0 
100 0 
92.5 7.5 
60 40 
0 100 
71 
 
- 71%; 
 
 
 
 Fig 34. Area chart showing Malignancy distribution in TIRADS system
Fig 35.Line diagram showing Malignancy distribution in TIRADS 
system 
Table.9. Malignancy distribution in 4b
 BENIGN 
4b 37 
 
 
 
MALIGNANT TOTAL 
3 40 
72 
 
 
  
Fig 36. Bar diagram showing 
Fig.37. Pie chart showing Malignancy distribution in 4b
Table 10.Malignancy distribution in 4c
 
BENIG
N 
MALIG
NANT
4c 9 6 
 
 
 
Malignancy distribution in 4b
 
 
 
 
 
TOTAL 
15 
73 
 
 Fig.38. Bar diagram showing Malignancy distribution in 4c
Fig 39. Pie chart showing 
Malignant nodules first appeared in TIRADS 4b with incidence of 
7.5%. TIRADS 4c showed an incidence of 40% which rose to 100% in 
TIRADS. 
 COMPARISON OF TIRADS, FNAC AND HPE
Of the 100 cases studied,FNAC correlated with 96 
showed different diagnosis. All the 4 cases belonged to TIRADS class 4c. 2 
cases where FNAC showed adenomatous goitre were found to be papillary 
carcinoma and follicular carcinoma each.
 
Malignancy distribution in 4c 
 
 
cases. Only 4 cases 
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1 case of colloid goitre in FNAC was found to be papillary carcinoma on 
biopsy. 
1 case of Hashimotos thyroiditis proved to be papillary carcinoma in biopsy. 
All the 4 cases were grouped under TIRADS 4c (suspicious lesion with 3 or 
4 suspicious sonographic features.) 
 So, of the 15 cases in TIRADS 4c,10 cases became malignant and 5 cases 
benign as per HPE.So percentage of malignancy in TIRADS 4c is 66.7% and 
33.3% benign lesion. 
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SIGNIFICANCE OF HIGH RISK SONOGRAPHIC FEATURES 
1.SOLID COMPONENTS 
Table 11.2 * 2 Table showing significance of solid components 
SOLID 
COMPONENTS 
MALIGNANCY 
TOTAL 
YES NO 
YES 20 61 81 
NO 0 14 14 
TOTAL 20 75 95 
 
 
1 SENSITIVITY 20/20*100 100 
2 SPECIFICITY 14/75*100 18.7 
3 POSITIVE PREDICTIVE VALUE 20/81*100 24.7 
4 NEGETIVE PREDICTIVE VALUE 14/14*100 100 
5 ACCURACY 34/95*100 35.8 
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Table 12.2 * 2 Table showing significance of hypoechogenicity 
HYPOECHOGE
NICITY 
MALIGNANCY 
TOTAL 
YES NO 
YES 20 53 73 
NO 0 19 19 
TOTAL 20 72 92 
 
 
1 SENSITIVITY 20/20*100 100 
2 SPECIFICITY 19/72*100 26.4 
3 
POSITIVE PREDICTIVE 
VALUE 
20/73*100 27.4 
4 
NEGETIVE PREDICTIVE 
VALUE 
19/19*100 100 
5 ACCURACY 39/92*100 42.4 
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Table 13.2 * 2 Table showing significance of micro calcification 
MICROCAL CIFICATION 
MALIGNANCY 
TOTAL 
YES NO 
YES 15 6 21 
NO 5 63 68 
TOTAL 20 69 89 
 
 
 
1 SENSITIVITY 15/20*100 75 
2 SPECIFICITY 63/69*100 91.3 
3 
POSITIVE PREDICTIVE 
VALUE 
15/21*100 71.4 
4 
NEGETIVE PREDICTIVE 
VALUE 
63/68*100 92.65 
5 ACCURACY 78/89*100 87.6 
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Table 14.2 * 2 Table showing significance of taller than wider 
TALLER THAN 
WIDER 
MALIGNANCY 
TOTAL 
YES NO 
YES 12 4 16 
NO 8 65 73 
TOTAL 20 69 89 
 
1 SENSITIVITY 12/20*100 60 
2 SPECIFICITY 65/69*100 94.2 
3 
POSITIVE PREDICTIVE 
VALUE 
12/16*100 75 
4 
NEGETIVE 
PREDICTIVE VALUE 
65/73*100 89 
5 ACCURACY 77/89*100 86.5 
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Table 15. 2 * 2 Table showing significance of irregular margins 
IRREGULAR 
MARGINS 
MALIGNANCY 
TOTAL 
YES NO 
YES 16 4 20 
NO 4 65 69 
TOTAL 20 69 89 
 
 
1 SENSITIVITY 16/20*100 80 
2 SPECIFICITY 65/69*100 94.2 
3 
POSITIVE PREDICTIVE 
VALUE 
16/20*100 80 
4 
NEGETIVE PREDICTIVE 
VALUE 
65/69*100 94.2 
5 ACCURACY 81/89*100 91 
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DISCUSSION 
Thyroid swellings were seen to affect mainly females within the age 
group of 30-40 years in the above series. Female to male ratio was found to 
be 13.2:1. 20% of the cases were found to have malignancy, of which 
papillary carcinoma accounted for 60%, follicular neoplasm 20%, not 
specified malignancy 15% and anaplastic carcinoma 5%. When classified 
into TIRADS, majority of them fell into TIRADS 4 (71%). TIRADS 4b 
showed incidence of malignancy of 7.5%, TIRADS 4c - 66.7%, TIRADS 5 - 
100%. Study by Horvath et al showed malignancy rate in TIRADS 3 - <5%; 
TIRADS 4a- 5-10%; TIRADS 4b - 10-80%; TIRADS 4c - >80%. The 
suspicious sonographic features were evaluated. Solid components and 
hypoechogenicity were found to be maximum sensitive but less specific. 
Sensitivity, specificity ,positive predictive value,negative predictive value 
were found to be maximum for irregular margins (80, 94.2, 80, 94.2, 91 
resp.). 
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Significance of suspicious sonographic features 
PARAMETER 
SENSIT
IVITY 
SPECIF
ICITY 
POSITIVE 
PREDICTIV
E VALUE 
NEGETIVE 
PREDICTIV
E VALUE 
ACCU
RACY 
SOLID 
COMPONENTS 
100 18.7 23.8 100 35.1 
HYPOECHOGENIC
ITY 
100 26.4 26.4 100 41.8 
MICROCALCIFICA
TION 
79 91.4 71.4 94 68.2 
TALLER THAN 
WIDER 
63.2 94.2 75 90.3 87.5 
IRREGULAR 
MARGINS 
84.2 94.2 80 95.6 92 
Study by Frates, Benson, Charboneau 
PARAMETER SENSITIVITY 
SPECIFICI
TY 
POSITIVE 
PREDICTIVE 
VALUE 
NEGETIVE 
PREDICTIVE 
VALUE 
SOLID 
COMPONENTS 69-75 53-56 16-27 88-92 
HYPOECHOGEN
ICITY 27-87 43-94 11-- 68 74-94 
MICROCALCIFI
CATION 26-59 86-95 24-71 42-94 
TALLER THAN 
WIDER 33 93 67 75 
IRREGULAR 
MARGINS 17-78 39-85 9--60 39-98 
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CONCLUSION 
1. ULTRASOUD THYROID PLAYS A MAJOR ROLE IN THE 
EVALUATION OF THYROID SWELLINGS AS IT PROVIDES 
SUSPICIOUS SONOLGRAPHIC FEATURES TO CLASSIFY 
PATIENT INTO HIGH RISK. FURTHER WHEN ULTRASOUND 
GUIDED FNAC IS USED, IT ENHANCES THE DIAGNOSTIC 
OUTCOME. 
2. TIRADS CLASSIFICATION CAN STANDARDISE THE 
ULTRASOUND FINDINGS SO AS TO SELECT AT RISK 
PATIENTS REQUIRING DETAILED EVALUATION. 
3. TIRADS 4b INCLUDED MAXIMUM CASES WITH 7.5% 
MALIGNANT CHANCES. TIRADS 4c SHOWED 66.7% 
MALIGNANCY AND TIRADS 5 SHOED 100% MALIGNANCY. 
4. THE SIGNIFICANCE OF VARIOUS SUSPICIOUS 
SONOGRAPHIC FEATURES STUDIED SHOWED IRREGULAR 
MARGIN AS MOST ACCURATE FEATURE SUGGESTIVE OF 
MALIGNANCY. TALLER THAN WIDER AND 
MICROCALCIFICATIONS ALSO HAVE HIGH CHANCE OF 
MALIGNANCY WHEN COMPARED TO SOLID COMPONENTS 
AND HYPOECHOGENICITY. 
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5. ULTRASOUND IS SIMPLE, SAFE, QUICK AND NONINVASIVE. 
IT SHOULD BE EXPLOITED TO ITS MAXIMUM BENEFIT FOR 
ALL THYROID SWELLINGS. 
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SUMMARY 
 100 patients were studied from January 2014 to June 2015. 
The TIRADS Class was compared with the cytological diagnosis in 
these cases. 
Majority of thyroid cases (58%) were in the 4 thand 5th decades of life 
(31-50) yrs, 93 were females and 7 were males,  
Females :    Males   =   13.2  :  1 
Of the 100 cases 80 were benign and 20 malignant. Papillary carcinoma was 
the most common malignancy (60%) , follicular - 20% , nonspecified 
malignancy 15% , anaplastic - 5%. 
Incidence of malignancy in TIRADS 4a was 0%, TIRADS 4b - 7.5% , 
TIRADS 4c - 66.7% , TIRADS 5 - 100%. 
Sensitivity, specificity, positive predictive value, negetive predictive value 
and accuracy, respectively, for each of the suspicious sonographic features 
were : 
1.solid components : 100, 18.7, 24.7, 100, 35.8 
2.Hypoechogenicity : 100, 26.4, 27.4, 100, 42.4 
3.Microcalcification : 75, 91.3, 71.4, 92.7, 87.6 
4.Taller than wider : 60, 94.2, 75, 89, 86.5 
5.Irregular margins : 80, 94.2, 80, 94.2, 91 
 
 
86 
 
LIMITATIONS OF STUDY 
The study sample selected is not a representative of the general 
population. Therefore the true incidence of various thyroid pathologies 
couldnot be assessed.. 
The number of malignant cases studied during this limited period was 
not sufficient enough to make concrete conclusions, as regard to the 
sensitivity, specificity and accuracy of various sonographic features. 
  The experience of the Radiologist is an important factor affecting the 
outcome of the study. 
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PROFORMA 
 
Name    :                               
Age     :            Sex  :        IP.No.   : 
 
History    :                                              
 
Thyroid function tests  :               
 
USG    : 
 
TIRADS class  : 
 
Clinical diagnosis  : 
    
FNAC Report  :                   
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STATISTICAL METHODS APPLIED 
 
The following statistical methods were applied in the present study 
1. Cross tabs procedure 
2. Descriptive statistics 
3. Sensitivity 
4. Specificity 
5. Positive predictive value 
6. Negative predictive value 
7. Accuracy  
 
Cross tabs Procedure 
The cross tabs procedure forms two way and multi way tables and 
provides a variety of tests and measures of association for two-way tables. 
The structure of the table and whether categories are ordered determine what 
test or measure to use. 
Cross tabs statistics and measures of association are computed for two 
way tables only. 
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Descriptive statistics 
This provides summary, information about the distribution, variability 
and central tendency of a variable.   
 
Sensitivity  
It is computed as follows Sensitivity   = 
FNTP
100TP
+
×
 
 Specificity 
 It is computed as follows Specificity   =    
FPTN
100TN
+
×
 
 
Positive predictive value 
It is computed as follows Positive predictive  
value =  
FPTP
100TP
+
×
 
 
 Negative predictive value 
It is computed as follows Negative predictive  
value =  
FNTN
100TN
+
×
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Accuracy 
It is computed as follows                                              
ACCURACY     =    TP  +   TN  *100 
                                 TP+TN+FP+FN    
 
Where TP,TN,FP and FN imply True Positive, True Negative, False Positive 
and False Negative respectively.  
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MASTER CHART 
 
 
NAME 
AGE SEX IP NO: 
BIOCHEMICAL 
STATUS 
NODU
LARIT
Y 
SOLID 
COMPONE
NTS 
HYPOECHO
GENICITY 
MICROCAL
CIFICATION 
TALLER 
THAN 
WIDE 
IRREGUL
AR 
MARGINS 
TIRADS FNAC (HPE) 
SARASWATHY 42 F 72478 HYPER Y Y Y N N N 4b COLLOID GOITRE 
LAKSHMI 34 F 807 EU Y Y Y N N N 4b COLLOID GOITRE 
MAHALAKSHMI 29 F 1086 HYPO N N Y N N N 2 HASHIMOTOS 
MEENA 34 F 3867 EU Y Y Y N N N 4b COLLOID GOITRE 
MARIAMMAL 30 F 4120 EU Y Y Y N N N 4b COLLOID GOITRE 
THANGAM 69 F 4388 EU Y Y Y Y Y Y 5 ANAPLATIC CA 
ANBUJAM 55 F 3555 EU Y Y N N N N 4a COLLOID GOITRE 
KALAVATHY 34 F 6252 EU Y Y Y Y Y Y 5 PAPILLARY CA 
SHANTHI 40 F 4764 EU Y Y Y N N Y 4c MALIGNANCY 
ANNALREENA 35 F 983 EU Y Y Y Y N N 4c 
COLLOID GOITRE 
(PAPILLARY 
CARCINMA) 
VAIGUNDA MANI 60 F 24014 EU Y Y Y Y N Y 4c 
ADENOMA 
(PAPILLARY 
CARCINOMA) 
ULAGAMMAL 37 F 74877 EU Y N Y N N N 4a COLLOID GOITRE 
AVUDIAMMAL 60 F 14849 EU Y Y N N N N 4a COLLOID GOITRE 
JOYAL 32 F 18005 EU Y Y Y N Y N 4c COLLOID GOITRE 
CHERMAKANI 45 F 18934 EU Y N Y N N N 4a COLLOID GOITRE 
ADHISAYAMANI 40 F 43328 EU Y Y N N Y N 4b COLLOID GOITRE 
NAGOORFATIMA 70 F 18688 EU Y Y N N N N 4a COLLOID GOITRE 
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MURUGANATHN 43 M 17702 HYPER Y Y Y N N N 4b COLLOID GOITRE 
PARVATHY 52 F 18708 EU Y Y Y Y Y N 4c PAPILLARY CA 
SAMUTHRAKANI 36 F 20668 EU Y Y N N N N 4a COLLOID GOITRE 
MARIAMMAL 63 F 19282 EU Y N Y N N N 4a COLLOID GOITRE 
SARASWATHI 52 F 19474 HYPER Y N N N N N 3 COLLOID GOITRE 
ALAGAR 35 F 20907 EU Y N N N N N 3 COLLOID GOITRE 
VIJAYARANI 37 F 20893 EU Y N N N N N 3 COLLOID GOITRE 
SELVI 51 F 22959 EU Y Y Y N N N 4b COLLOID GOITRE 
RAMAIAH 75 M 20690 EU Y Y Y Y N Y 4c PAPILLARY CA 
RAMALAKSHMI 40 F 206703 EU Y Y Y N N N 4b COLLOID GOITRE 
MARAMANI 38 F 26645 HYPER Y Y Y N N N 4b COLLOID GOITRE 
THEVANAI 65 F 21871 EU Y Y Y Y N Y 4c HASHIMOTOS 
SIKANDERBEEVI 48 F 27715 EU Y Y Y N N N 4b COLLOID GOITRE 
KALYANI 55 F 27306 EU Y Y Y N N N 4b COLLOID GOITRE 
MURUGAMMAL 40 F 27061 EU N      1 NORMAL 
ULAGUMUTHU 50 F 27821 EU Y Y Y N Y N 4c COLLOID GOITRE 
SIVANAMMAL 30 F 30765 EU Y Y Y Y N N 4c COLLOID GOITRE 
KOKILA 26 F 28140 EU N      2 HASHIMOTS 
RAMALAKSHMI 40 F 26703 SC HYPO Y Y N N N N 4a COLLOID GOITRE 
LAKSHMI 46 F 31331 EU N Y Y    2 LYMPHOCYTIC 
THYROIDITIS 
ULAGUMATHA 50 F 29176 EU N      2 HASHIMOTS 
KUMARI 36 F 28900 EU Y Y Y N N N 4b COLLOID GOITRE 
JAYANTHI 36 F 37183 EU Y Y Y N N N 4b COLLOID GOITRE 
MUTHUSELVI 30 F 37651 EU Y Y Y N N N 4b FOLLICULAR 
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ADENOMA 
PALAVESAM 54 F 37442 EU Y Y Y N N N 4b COLLOID GOITRE 
PARVATHY 50 F E N Y Y     2 HASHIMOTOS 
THANGAM 36 F 42030 EU Y Y Y N N N 4b COLLOID GOITRE 
ESAKKIAMMAL 40 F 42257 EU N Y     2 HASHIMOTOS 
AMMAPONNU 70 F 41009 EU Y Y Y N Y Y 4c HURTHLE CELL 
NEOPLASM 
ANNAL 37 F 43045 EU Y Y Y Y Y Y 5 PAPILLARY CA 
ANTONYAMMAL 65 F 37133 EU Y Y Y N N N 4b COLLOID GOITRE 
HAMARNIS 40 F 97141 HYPER Y Y Y N N N 4b COLLOID GOITRE 
JEYAPANDI 40 M 43674 EU N      2 HASHIMOTOS 
POOLKOTHAI 47 F 48288 EU Y Y Y N N N 4b COLLOID GOITRE 
SOORYAKALA 41 F 48846 EU Y Y Y N N N 4b COLLOID GOITRE 
SUGUNA 31 F 37896 EU Y Y Y Y N Y 4c PAPILLARY CA 
PETCHIAMMAL 62 F 28018 EU Y Y Y Y N Y 4c 
ADENOMA 
(FOLLICULAR 
CARCINOMA) 
MARIAMMAL 32 F 28861 EU Y N Y N N N 4a COLLOID GOITRE 
ULAGAMMAL 58 F 24849 EU Y Y N N N N 4a COLLOID GOITRE 
CHELLAMMAL 27 F 41562 SC HYPO Y Y Y Y N Y 4c PAPILLARY CA 
AVUDIAMMAL 36 F 18086 Y Y Y N N N N 4b COLLOID GOITRE 
JOYAL 44 F 28934 SC HYPO Y N Y N N N 4a COLLOID GOITRE 
CHERMAKANI 40 F 23328 EU Y Y N N Y N 4b COLLOID GOITRE 
ADHISAYAMANI 42 F 43348 EU Y Y N N N N 4a COLLOID GOITRE 
NAGOORFAHIMA 68 F 18738 EU Y Y N N N N 4a COLLOID GOITRE 
MURUGANATHN 42 M 17808 EU Y Y Y N N N 4b COLLOID GOITRE 
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PARVATHY 50 F 19808 EU Y Y Y Y Y Y 5 PAPILLARY CA 
MARIKODI 36 F 20672 EU Y Y N N N N 4a COLLOID GOITRE 
MARIAMMAL 62 F 19268 EU Y N Y N N N 4a COLLOID GOITRE 
MURUGANATHN 53 M 19806 EU Y Y Y Y Y Y 5 PAPILLARY CA 
SARASWATHI 52 F 19482 HYPER Y N N N N N 3 COLLOID GOITRE 
NAGALAKSHMI 51 F 28086 EU Y N N N N N 3 COLLOID GOITRE 
ALAGAR 36 F 20908 EU Y N N N N N 3 COLLOID GOITRE 
SELVI 51 F 23986 EU Y Y Y N N N 4b COLLOID GOITRE 
RAMU 75 M 20690 EU Y Y Y Y Y Y 5 PAPILLARY CA 
RAMALAKSHMI 40 F 26802 EU Y Y Y N N N 4b COLLOID GOITRE 
LAHSHMI 36 F 26845 EU Y Y Y N N N 4b COLLOID GOITRE 
SUDALAI 76 M 20890 EU Y Y Y Y Y Y 5 PAPILLARY CA 
DEVANAI 65 F 21986 HYPO Y Y Y Y N Y 4c 
HASHIMOTS(PAPI
LLARY 
CARCINOMA) 
REVATHY 48 F 28826 EU Y Y Y N N N 4b COLLOID GOITRE 
MURUGAMMAL 42 F 28082 EU N Y     1 NORMAL 
ULAGAMMAL 52 F 28821 EU Y Y Y N N N 4b COLLOID GOITRE 
SIVANAMMAL 30 F 30786 EU Y Y Y N N N 4b COLLOID GOITRE 
KAVITHA 28 F 28186 EU N      2 HASHIMOTOS 
RAMALAKSHMI 40 F 26786 SC HYPER Y Y N N N N 4a COLLOID GOITRE 
LALITHA 46 F 33138 EU Y Y Y N N N 4b LYMPHOCYTIC 
THYROIDITIS 
ALAGAMMAL 52 F 29188 EU N      2 HASHIMOTOS 
AMRITALAKSHMI 44 F 31868 EU N Y Y    2 LYMPHOCYTIC 
THYROIDITIS 
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RAMAKUMARI 37 F 38900 EU Y Y Y N N N 4b COLLOID GOITRE 
JEYALALITHA 35 F 36183 EU Y Y Y N N N 4b COLLOID GOITRE 
SELVI 32 F 37651 EU Y Y Y N N N 4b FOLLICULAR 
ADENOMA 
PALAVESAM 38 F 38623 EU Y Y Y N N N 4b FOLLICULAR 
ADENOMA 
BHARATHI 55 F 38612 EU Y Y Y N N N 4b COLLOID GOITRE 
SIVANAMMAL 40 F 37868 HYPER Y Y Y N N N 4b COLLOID GOITRE 
SETHULAKSHMI 32 F 28035 EU Y Y Y N N N 4b COLLOID GOITRE 
MAHALAKSHMI 30 F 10808 HYPO N Y Y    2 HASHIMOTS 
MEENA 32 F 38678 EU Y Y Y N N N 4b COLLOID GOITRE 
MARIKODI 30 F 41868 EU Y Y Y N N N 4b COLLOID GOITRE 
THANGAMARI 68 F 43861 EU Y Y Y Y Y Y 5 MALIGNANCY 
AMUTHA 55 F 35550 EU Y Y Y N N N 4b COLLOID GOITRE 
KALA 32 F 27836 EU Y Y Y Y Y Y 5 PAPILLARY CA 
SANTHA 42 F 47684 EU Y Y Y Y N Y 4c MALIGNANCY 
SHEELA 70 F 28692 EU Y Y Y Y Y Y 5 PAPILLARY CA 
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